J&J Gets Pa.'s Off-Label Risperdal Suit Tossed

Law360, New York (June 14, 2010, 7:29 PM EDT) -- A state court judge on Monday threw out the commonwealth of Pennsylvania's suit alleging that Johnson & Johnson unit Janssen Pharmaceutica Inc. had improperly marketed the antipsychotic drug Risperdal, and an attorney for Pennsylvania vowed to appeal.

Judge Frederica Massiah-Jackson of the Philadelphia Court of Common Pleas granted Janssen's motion for a nonsuit on Monday morning, J&J spokesman Greg Panico told Law360.

"We are pleased with the judge's decision, and the evidence presented by the plaintiffs failed to demonstrate that Janssen had committed any fraud on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.